Literature DB >> 30681366

Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.

Rachel Boardman1, Vincent Pang1, Naseeb Malhi1, Amy P Lynch1, Lopa Leach2, Andrew V Benest1,3, David O Bates1,3, Maria J C Machado1.   

Abstract

The Notch ligand delta-like ligand 4 (Dll4), upregulated by VEGF, is a key regulator of vessel morphogenesis and function, controlling tip and stalk cell selection during sprouting angiogenesis. Inhibition of Dll4 results in hypersprouting, nonfunctional, poorly perfused vessels, suggesting a role for Dll4 in the formation of mature, reactive, functional vessels, with low permeability and able to restrict fluid and solute exchange. We tested the hypothesis that Dll4 controls transvascular fluid exchange. A recombinant protein expressing only the extracellular portion of Dll4 [soluble Dll4 (sDll4)] induced Notch signaling in endothelial cells (ECs), resulting in increased expression of vascular-endothelial cadherin, but not the tight junctional protein zonula occludens 1, at intercellular junctions. sDll4 decreased the permeability of FITC-labeled albumin across EC monolayers, and this effect was abrogated by coculture with the γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester. One of the known molecular effectors responsible for strengthening EC-EC contacts is PKA, so we tested the effect of modulation of PKA on the sDll4-mediated reduction of permeability. Inhibition of PKA reversed the sDll4-mediated reduction in permeability and reduced expression of the Notch target gene Hey1. Knockdown of PKA reduced sDLL4-mediated vascular-endothelial cadherin junctional expression. sDll4 also caused a significant decrease in the hydraulic conductivity of rat mesenteric microvessels in vivo. This reduction was abolished upon coperfusion with the PKA inhibitor H89 dihydrochloride. These results indicate that Dll4 signaling through Notch activation acts through a cAMP/PKA pathway upon intercellular adherens junctions, but not tight junctions, to regulate endothelial barrier function. NEW & NOTEWORTHY Notch signaling reduces vascular permeability through stimulation of cAMP-dependent protein kinase A.

Entities:  

Keywords:  Notch; delta-like ligand 4; endothelial cells; vascular permeability

Mesh:

Substances:

Year:  2019        PMID: 30681366      PMCID: PMC6580391          DOI: 10.1152/ajpheart.00610.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

1.  A mechanosensory complex that mediates the endothelial cell response to fluid shear stress.

Authors:  Eleni Tzima; Mohamed Irani-Tehrani; William B Kiosses; Elizabetta Dejana; David A Schultz; Britta Engelhardt; Gaoyuan Cao; Horace DeLisser; Martin Alexander Schwartz
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

2.  Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.

Authors:  Nilay S Patel; Ji-Liang Li; Daniele Generali; Richard Poulsom; David W Cranston; Adrian L Harris
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.

Authors:  Zhao-Jun Liu; Takashi Shirakawa; Yan Li; Akinobu Soma; Masahiro Oka; G Paolo Dotto; Ronald M Fairman; Omaida C Velazquez; Meenhard Herlyn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

Authors:  J M Wood; G Bold; E Buchdunger; R Cozens; S Ferrari; J Frei; F Hofmann; J Mestan; H Mett; T O'Reilly; E Persohn; J Rösel; C Schnell; D Stover; A Theuer; H Towbin; F Wenger; K Woods-Cook; A Menrad; G Siemeister; M Schirner; K H Thierauch; M R Schneider; J Drevs; G Martiny-Baron; F Totzke
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  Effect of local anti-VEGF antibody treatment on tumor microvessel permeability.

Authors:  H C Lichtenbeld; N Ferarra; R K Jain; L L Munn
Journal:  Microvasc Res       Date:  1999-05       Impact factor: 3.514

6.  PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction.

Authors:  Jing Qiao; Fei Huang; Hazel Lum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-02-14       Impact factor: 5.464

7.  Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.

Authors:  Max Nieuwdorp; Timon W van Haeften; Mirella C L G Gouverneur; Hans L Mooij; Miriam H P van Lieshout; Marcel Levi; Joost C M Meijers; Frits Holleman; Joost B L Hoekstra; Hans Vink; John J P Kastelein; Erik S G Stroes
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

8.  cAMP protects endothelial barrier functions by preventing Rac-1 inhibition.

Authors:  J Waschke; D Drenckhahn; R H Adamson; H Barth; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-22       Impact factor: 4.733

9.  Opposite effect of cAMP signaling in endothelial barriers of different origin.

Authors:  K Bindewald; D Gündüz; F Härtel; S C Peters; C Rodewald; S Nau; M Schäfer; J Neumann; H M Piper; T Noll
Journal:  Am J Physiol Cell Physiol       Date:  2004-11       Impact factor: 4.249

10.  Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies.

Authors:  Gordon C Jayson; Jamal Zweit; Alan Jackson; Clive Mulatero; Peter Julyan; Malcolm Ranson; Lynn Broughton; John Wagstaff; Leif Hakannson; Gerard Groenewegen; John Bailey; Nigel Smith; David Hastings; Jeremy Lawrance; Hamied Haroon; Tim Ward; Alan T McGown; Meina Tang; Dan Levitt; Sandrine Marreaud; Frederic F Lehmann; Manfred Herold; Heinz Zwierzina
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

View more
  4 in total

1.  Enhanced notch signaling modulates unproductive revascularization in response to nitric oxide-angiopoietin signaling in a mouse model of peripheral ischemia.

Authors:  Maria J C Machado; Rachel Boardman; Federica Riu; Costanza Emanueli; Andrew V Benest; David O Bates
Journal:  Microcirculation       Date:  2019-06-19       Impact factor: 2.628

2.  Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.

Authors:  Wei Wang; Wentao Hu; Ya Wang; Yong An; Lei Song; Panfeng Shang; Zhongjin Yue
Journal:  Mol Cancer       Date:  2020-01-29       Impact factor: 27.401

3.  Reciprocal communication between astrocytes and endothelial cells is required for astrocytic glutamate transporter 1 (GLT-1) expression.

Authors:  Zila Martinez-Lozada; Michael B Robinson
Journal:  Neurochem Int       Date:  2020-07-08       Impact factor: 3.921

4.  Notch Ligand Delta-Like 1 Is Associated With Loss of Vascular Endothelial Barrier Function.

Authors:  Maximilian Moll; Konrad Reichel; Dennis Nurjadi; Sandra Förmer; Lars Johannes Krall; Klaus Heeg; Dagmar Hildebrand
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.